化合物Telratolimod T17032

Product Introduction
Bioactivity


英文名: Telratolimod

描述: Telratolimod (MEDI9197) 是TLR7/8的激动剂，具有抗肿瘤活性。

体内活性: Telratolimod (50 μg) suppresses the tumor volume and more effectively blocks tumor growth in combination with CpG ODN in BALB/c mice bearing CT26 colon carcinoma cells. Telratolimod (100 μg) plus 200 μg of CpG ODN slows tumor growth and prolongs the survival of mice bearing large tumors [1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 60 mg/mL (101.02 mM)


关键字: Toll-like Receptor (TLR) | inhibit | 3M 052 | Inhibitor | Telratolimod | MEDI 9197 | MEDI-9197 | 3M052

相关产品: E6446 | Semapimod tetrahydrochloride | CL097 | CU-T12-9 | ABR-238901 | SM-324405 | Toll-like receptor modulator | RS09 2TFA (1449566-36-2 free base) | MyD88-IN-1 | Polyinosinic-polycytidylic acid sodium

相关库: Drug Repurposing Compound Library | Pyroptosis Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Immuno-Oncology Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Active Compound Library | Reprogramming Compound Library | Bioactive Compound Library

化合物Telratolimod T17032信息由TargetMol中国为您提供，如您想了解更多关于化合物Telratolimod T17032报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途